InvestorsHub Logo
Followers 116
Posts 1882
Boards Moderated 0
Alias Born 11/22/2017

Re: JTORENCE post# 251986

Sunday, 11/17/2019 11:12:37 AM

Sunday, November 17, 2019 11:12:37 AM

Post# of 709758

As is typical for a trial of this size, the electronic sNDA submission consists of over 5 million pages of information regarding Vascepa, including data from over 35,000 patient years of study in REDUCE-IT.
https://investor.amarincorp.com/news-releases/news-release-details/amarin-submits-supplemental-new-drug-application-snda-us-fda



I don't expect anything like that in our DCVax-L trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News